These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet lactate dehydrogenase activity in systemic lupus erythematosus: correlation with anticardiolipin antibodies. Zoli A; Zappacosta B; Altomonte L; De Sole P; Caricchio R; Pellegrino M; Mirone L; Giardina B; Magaro M J Rheumatol; 1995 Apr; 22(4):649-53. PubMed ID: 7791157 [TBL] [Abstract][Full Text] [Related]
3. The significance of the assays of urinary enzymes activity in patients with systemic lupus erythematosus. Delektorskaya L; Janushkevich T; Okunev D Z Med Lab Diagn; 1990; 31(7):375-9. PubMed ID: 1982635 [TBL] [Abstract][Full Text] [Related]
4. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. Burling F; Ng J; Thein H; Ly J; Marshall MR; Gow P Lupus; 2007; 16(10):830-7. PubMed ID: 17895308 [TBL] [Abstract][Full Text] [Related]
5. [SLE: Extra-renal clinical manifestations and lupus nephritis]. Gallelli B; De Angelis V; Ventura D; Meroni PL; Moroni G G Ital Nefrol; 2005; 22 Suppl 33():S3-10. PubMed ID: 16419003 [TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [TBL] [Abstract][Full Text] [Related]
7. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus]. Serikova SIu; Kozlovskaia NL; Shilov EM Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477 [TBL] [Abstract][Full Text] [Related]
8. Serum lactate dehydrogenase and its isozymes in lupus nephritis. Inoue T; Okamura M; Amatsu K; Negoro N; Koda S; Kohno M; Takeda T; Kanayama Y Arch Intern Med; 1986 Mar; 146(3):548-52. PubMed ID: 3954528 [TBL] [Abstract][Full Text] [Related]
9. [Expression of monocyte chemoattractant protein-1 and lupus nephritis]. Liu ZJ; Lin JY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome]. Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045 [TBL] [Abstract][Full Text] [Related]
12. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis]. Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus. Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907 [TBL] [Abstract][Full Text] [Related]
14. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260 [TBL] [Abstract][Full Text] [Related]
15. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome]. Kozlovskaia NL; Kabaenkova GS; Varshavskiĭ VA; Shvetsov MIu Klin Med (Mosk); 1995; 73(3):93-6. PubMed ID: 8577127 [TBL] [Abstract][Full Text] [Related]
16. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis. Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165 [TBL] [Abstract][Full Text] [Related]
17. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629 [TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. Vu TV; Escalante A J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368 [TBL] [Abstract][Full Text] [Related]
20. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus. Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]